By Amruta Khandekar and Bhanvi Satija (Reuters) – Initial public offerings by small private biotech companies are poised to stage a comeback later in 2023 as the pace of interest rate hikes slow[...]
Read more
Health
Martin Shkreli: I’m not in contempt over drug industry ban
By Jonathan Stempel NEW YORK (Reuters) – Martin Shkreli on Friday urged a U.S. judge not to hold him in civil contempt for failing to provide federal and state regulators with information to det[...]
Read more
AbbVie sees 37% drop in Humira sales this year as biosimilars hit U.S. market
By Leroy Leo and Mariam ESunny (Reuters) – AbbVie Inc said on Thursday it expects sales of its flagship rheumatoid arthritis drug Humira to decline 37% this year due to competition from cheaper[...]
Read more
Yellen says China should delay some debt demands, move faster on restructurings
WASHINGTON (Reuters) – U.S. Treasury Secretary Janet Yellen said on Thursday that she wants China to move more quickly to support specific debt restructurings for developing countries, especiall[...]
Read more
AstraZeneca goes for growth with new drugs as COVID sales wane
By Natalie Grover and Maggie Fick LONDON (Reuters) – AstraZeneca on Thursday said it was poised to grow in 2023 and beyond, banking on its burgeoning line-up of cancer, metabolic and rare diseas[...]
Read more
Elon Musk’s Neuralink may have illegally transported pathogens, animal advocates say
By Rachael Levy (Reuters) – An animal-welfare organization said it plans to ask a U.S. government agency on Thursday to investigate Elon Musk’s brain-implant company Neuralink over records[...]
Read more
Centene reaches $215 million settlement addressing California drug overcharges
By Jonathan Stempel (Reuters) – Centene Corp has reached a $215.4 million settlement with California to resolve accusations it overcharged a state program for affordable healthcare by falsely in[...]
Read more
CVS Health beats quarterly profit estimates on lower medical costs
(Reuters) – CVS Health beat quarterly profit estimates on Wednesday, as a decline in hospitalizations from COVID-19 helped bring down medical costs at its Aetna insurance business. The company p[...]
Read more
Unilever to build Mexico plant as part of $400 million investment
MEXICO CITY (Reuters) – Unilever Plc will build a manufacturing plant in the northern Mexican border state Nuevo Leon as part of a $400 million investment in the country over the next three year[...]
Read more